Earnings

Which is more compelling pick right now? – Schlumberger Limited (SLB), Eli Lilly and Company (LLY)

The shares of Schlumberger Limited have increased by more than 6.25% this year alone. The shares recently went up by 0.73% or $0.52 and now trades at $71.60. The shares of Eli Lilly and Company (NYSE:LLY), has slumped by -1.65% year to date as of 05/14/2018. The shares currently trade at $83.07 and have been able to report a change of 5.65% over the past one week.

The stock of Schlumberger Limited and Eli Lilly and Company were two of the most active stocks on Monday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

Next 5Y EPS Growth: 47.35% versus 11.80%

When a company is able to grow consistently in terms of earnings at a high compound rate have the highest likelihood of creating value for its shareholders over time. Analysts have predicted that SLB will grow it’s earning at a 47.35% annual rate in the next 5 years. This is in contrast to LLY which will have a positive growth at a 11.80% annual rate. This means that the higher growth rate of SLB implies a greater potential for capital appreciation over the years.

Profitability and Returns

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. SLB has an EBITDA margin of 20.08%, this implies that the underlying business of LLY is more profitable. The ROI of SLB is -1.90% while that of LLY is 6.60%. These figures suggest that LLY ventures generate a higher ROI than that of SLB.

Cash Flow



The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, SLB’s free cash flow per share is a negative -1.87, while that of LLY is also a negative -1.76.

Liquidity and Financial Risk

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for SLB is 1.10 and that of LLY is 1.40. This implies that it is easier for SLB to cover its immediate obligations over the next 12 months than LLY. The debt ratio of SLB is 0.49 compared to 0.81 for LLY. LLY can be able to settle its long-term debts and thus is a lower financial risk than SLB.

Valuation

SLB currently trades at a forward P/E of 23.50, a P/B of 2.69, and a P/S of 3.16 while LLY trades at a forward P/E of 14.97, a P/B of 5.99, and a P/S of 3.71. This means that looking at the earnings, book values and sales basis, SLB is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

Analyst Price Targets and Opinions




The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of SLB is currently at a -10.19% to its one-year price target of 79.72. Looking at its rival pricing, LLY is at a -8.16% relative to its price target of 90.45.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), SLB is given a 2.00 while 2.20 placed for LLY. This means that analysts are more bullish on the outlook for LLY stocks.

Insider Activity and Investor Sentiment

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for SLB is 2.79 while that of LLY is just 2.25. This means that analysts are more bullish on the forecast for LLY stock.

Conclusion

The stock of Schlumberger Limited defeats that of Eli Lilly and Company when the two are compared, with SLB taking 6 out of the total factors that were been considered. SLB happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, SLB is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for SLB is better on when it is viewed on short interest.

Previous ArticleNext Article

Related Post

A Side-by-side Analysis of Boston Scientific Corpo... Boston Scientific Corporation (NYSE:BSX) shares are up more than 7.99% this year and recently increased 1.02% or $0.27 to settle at $26.77. Norwegian ...
Should You Buy Sirius XM Holdings Inc. (SIRI) or P...   Sirius XM Holdings Inc. (NASDAQ:SIRI) shares are up more than 20.00% this year and recently decreased -1.84% or -$0.1 to settle at $5.34. Pa...
Financial Metrics You Should Care About: Genworth ... The shares of Genworth Financial, Inc. have decreased by more than -11.25% this year alone. The shares recently went down by -2.82% or -$0.08 and now ...
Philip Morris International Inc. (PM) vs. DENTSPLY... Philip Morris International Inc. (NYSE:PM) shares are down more than -2.65% this year and recently decreased -1.40% or -$1.46 to settle at $102.85. DE...
Comparing Bristol-Myers Squibb Company (BMY) and H... Bristol-Myers Squibb Company (NYSE:BMY) shares are up more than 2.15% this year and recently decreased -2.13% or -$1.36 to settle at $62.60. Heron The...